| LP231800-6 | W 18F-FDG IV | CHALLENGE | |
| LP231801-4 | Nurse summary note - recommended sections | COMPONENT | 1 |
| LP231878-2 | Multiplex allergen panel | COMPONENT | 1 |
| LP231879-0 | HBA2 gene alpha 3.7kb triplication | COMPONENT | 1 |
| LP231880-8 | Maprotiline and normaprotiline panel | COMPONENT | 1 |
| LP231881-6 | Sinuses and Mandible | SYSTEM | 1 |
| LP231882-4 | Head and Temporal bone | SYSTEM | 3 |
| LP231883-2 | Superior mediastinum | SYSTEM | |
| LP231884-0 | Neck and Superior mediastinum | SYSTEM | 3 |
| LP231886-5 | Chest vessels and Abdominal vessels and Pelvis vessels | SYSTEM | 2 |
| LP231887-3 | for calcium scoring WO contrast | COMPONENT | 2 |
| LP231888-1 | D-3-phosphoglycerate dehydrogenase IgG | COMPONENT | 1 |
| LP231889-9 | D-3-phosphoglycerate dehydrogenase Ab | COMPONENT | |
| LP231890-7 | Myelin oligodendrocyte glycoprotein | COMPONENT | |
| LP231891-5 | Myelin oligodendrocyte glycoprotein Ab | COMPONENT | 4 |
| LP231892-3 | Myelin oligodendrocyte glycoprotein IgG | COMPONENT | 2 |
| LP231893-1 | Escitalopram+norescitalopram | COMPONENT | 1 |
| LP231894-9 | Escitalopram and norescitalopram panel | COMPONENT | 1 |
| LP231895-6 | Does the patient walk - discharge performance | COMPONENT | |
| LP231896-4 | Norescitalopram | COMPONENT | 1 |
| LP231897-2 | Nitisinone | COMPONENT | 1 |
| LP231898-0 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 3.00 | COMPONENT | 1 |
| LP231900-4 | LCDS v3.00 - Mobility - admission performance during 3 day assessment period | COMPONENT | 1 |
| LP231901-2 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 3.00 | COMPONENT | 1 |
| LP231902-0 | LCDS v3.00 - Functional abilities and goals - planned discharge | COMPONENT | 1 |
| LP231904-6 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 3.00 | COMPONENT | 1 |
| LP231905-3 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 3.00 | COMPONENT | 1 |
| LP231906-1 | Myoglobin casts | COMPONENT | 1 |
| LP231907-9 | Citalopram and norcitalopram and didesmethylcitalopram panel | COMPONENT | 1 |
| LP231908-7 | Dothiepin and nordothiepin and dothiepin sulfoxide panel | COMPONENT | 1 |
| LP231909-5 | Liver diseases autoimmune IgG panel | COMPONENT | 1 |
| LP231910-3 | Crystal casts | COMPONENT | 4 |
| LP231912-9 | Cells.chromosome region 7q31 deletion | COMPONENT | |
| LP231913-7 | Cells.chromosome region 7q31 | COMPONENT | |
| LP231914-5 | Cells.chromosome region 5q31 | COMPONENT | |
| LP231915-2 | Cells.chromosome region 5q31 deletion | COMPONENT | |
| LP231921-0 | Injection drug use in the past year | COMPONENT | 1 |
| LP231922-8 | Exchanged drugs AndOr money for sex in the past year | COMPONENT | 1 |
| LP231923-6 | Sexual activity while intoxicated AndOr high on drugs in the past year | COMPONENT | 1 |
| LP231924-4 | Sexual activity with known intravenous drug user in the past year | COMPONENT | 1 |
| LP231925-1 | Sexual activity with anonymous partner in the past year | COMPONENT | 1 |
| LP231926-9 | Sexual activity with a male in the past year | COMPONENT | 1 |
| LP231927-7 | Sexual activity with a female in the past year | COMPONENT | 1 |
| LP231934-3 | Hexanoate (C6:0) | COMPONENT | 1 |
| LP231936-8 | Epstein Barr virus capsid p18 Ab | COMPONENT | |
| LP231951-7 | Elastase IgG | COMPONENT | 1 |
| LP231952-5 | Cells.chromosome region 17p13.1 deletion | COMPONENT | |
| LP231953-3 | Cells.chromosome region 17p13.1 | COMPONENT | |
| LP231954-1 | Cells.chromosome region 11q22.3 | COMPONENT | |
| LP231955-8 | Cells.chromosome region 13q14 | COMPONENT | |